bromfenac   Click here for help

GtoPdb Ligand ID: 7131

Synonyms: AHR-10282B | Bromday® | Prolensa® | Xibrom®
Approved drug PDB Ligand Immunopharmacology Ligand
bromfenac is an approved drug (FDA (2004), EMA (2011))
Compound class: Synthetic organic
Comment: Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID).
Marketed formulations may contain bromfenac sodium (PubChem CID 23693301).
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: bromfenac

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 80.39
Molecular weight 333
XLogP 3.41
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES OC(=O)Cc1cccc(c1N)C(=O)c1ccc(cc1)Br
Isomeric SMILES OC(=O)Cc1cccc(c1N)C(=O)c1ccc(cc1)Br
InChI InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19)
No information available.
Summary of Clinical Use Click here for help
Used to minimise clouding of the lens caused by post-operative inflammation following cataract removal.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
As with other NSAIDs, this drug reduces prostaglandin synthesis by reducing cyclooxegenase (COX) activity.
External links Click here for help